Ocumension TherapeuticsOcumension TherapeuticsOcumension Therapeutics

Ocumension Therapeutics

No trades
See on Supercharts

Price target

1.220.000.00%
The 3 analysts offering 1 year price forecasts for 5DG have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to 5DG in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


5DG EPS for the last quarter is −0.02 EUR despite the estimation of −0.01 EUR. In the next quarter EPS is expected to reach −0.00 EUR. Track more of Ocumension Therapeutics financials and stay on top of what is up with the company.
In the next quarter Ocumension Therapeutics revenue is expected to reach ‪61.23 M‬ EUR. Check out Ocumension Therapeutics revenue and earnings and make informed decisions.
According to analysts, 5DG price target is 1.22 EUR with a max estimate of 1.35 EUR and a min estimate of 1.12 EUR. Check if this forecast comes true in a year, meanwhile watch Ocumension Therapeutics stock price chart and keep track of the current situation with 5DG news and stock market news.